Advertisement
Advertisement
NRSN
NeuroSense Therapeutics Ltd. Ordinary Shares
7.18
USDSponsored
+0.56
+8.46%
Sep 22, 15:59 UTC -4
Closed
After-Market
7.00
-0.18
-2.52%
NeuroSense Therapeutics Ltd. Ordinary Shares Financial Snapshot
| Market Cap | 13.28M |
| Beta | 1.60 |
| Earnings Per Share (EPS) | -- |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | -- |
| Free Cash Flow | 0.00 |
